The Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has ...

AstraZeneca (AZN) announced Enhertu in combination with pertuzumab has been granted Breakthrough Therapy Designation in the U ...

Astra Zeneca's Breast Cancer Leader Says Community Education is Crucial; Getting The Extraordinary Wave of Innovation To Patients Who Need Hope ...

AstraZeneca, which is working on the drug with Japan's Daiichi Sankyo , opens new tab, said on Monday that Enhertu prolonged survival and slowed the progression of metastatic breast cancer with ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Its big commercial potential, though, lies in treating HR-positive, HER2-negative breast cancer. Like most other pharma companies, AstraZeneca has to find ways to keep growing despite some of its ...

AstraZeneca and Daiichi Sankyo’s Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of ...

AstraZeneca said on Friday its experimental precision drug had slowed the progression of a common type of breast cancer in a late-stage trial, a boost for the company after its shares fell in July ...

Breast cancer patients may now benefit from two of AstraZeneca's existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.

L ONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly improve overall survival for patients with a type of breast cancer in a late ...

AstraZeneca announced on June 3 that Lynparza reduced the risk of relapse and death in breast cancer patients. Here's everything you need to know about the new treatment.